Skip to main content
Clinical Trials/JPRN-UMIN000045594
JPRN-UMIN000045594
Completed
Phase 2

A phase II study of collagen peptide-containing beverage during chemoradiotherapy for patients with head and neck cancer - A phase II study of collagen peptide-containing beverage during chemoradiotherapy for patients with head and neck cancer

Shizuoka Cancer Center0 sites33 target enrollmentSeptember 29, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
head and neck cancer
Sponsor
Shizuoka Cancer Center
Enrollment
33
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2021
End Date
July 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • i.Patients who are taking supplement or drugs containing collagen peptide, and who will continue to take them throughout the chemotherapy ii.Patients who will receive palliative chemoradiotherapy iii.Women who are pregnant, contemplating pregnancy or amid breast\-feeding iv.Mental disorders which is considered inappropriate for inclusion in the study v.Protein intake restriction vi.Hypersensitivity to the element of V CRESC vii.Unable to take V CRESC per oral viii.Any other cases who are regarded as inadequate for study enrollment by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials